The FDA has approved the pill version of the weight loss drug Wegovy, the first oral medication of its kind. The new pills are expected to be available in a few weeks. Chief medical correspondent Dr. Jon LaPook has more.
UN body to study possibility of integrating centuries-old practices into mainstream healthcareFrom herbalists in Africa gathering plants to use as poultices to acupuncturists in China using needles to cure migraines, or Indian yogis practising meditation, traditional remedies have increasingly being…
There is relatively little information on the long-term health effects of tattooing, but a couple of recent studies suggest the art form might trigger prolonged inflammation
We knew that GLP-1 drugs like Ozempic and Wegovy did more than just help control type 2 diabetes and aid weight loss, but the extent of that potential really came to light in 2025
The largest study so far into the genetics of chronic fatigue syndrome, or myalgic encephalomyelitis, has implicated 259 genes – six times more than those identified just four months ago
The Free Birth Society was selling pregnant women a simple message: they could exit the medical system and take back their power by free birthing. But Nicole Garrison believes FBS ideology nearly cost her her life. This is episode one of a year-long investigation by the Guardian journalists Sirin Ka…
Long before opioids flooded communities, something else was quietly changing—and it may have helped set the stage for today’s crisis. A new study finds that as church attendance dropped among middle-aged, less educated white Americans, deaths from overdoses, suicide, and alcohol-related disease bega…
A rare tick-borne allergy linked to red meat has now been confirmed as deadly for the first time. A healthy New Jersey man collapsed and died hours after eating beef, with later testing revealing a severe allergic reaction tied to alpha-gal, a sugar spread by Lone Star tick bites. Symptoms often app…
The neutropenic diet, which calls for nearly all food to be cooked at high heat to decrease infection risk, was waning in cancer care. A new study could change that.